The majority of HIV-infected individuals fail to produce protective antibodies and have diminished responses to new immunizations [1] [2] [3] . We report here that even though there is an expansion of follicular helper T (T FH ) cells in HIV-infected individuals, the cells are unable to provide adequate B cell help. We found a higher frequency of programmed cell death ligand 1 (PD-L1) + germinal center B cells from lymph nodes of HIV-infected individuals suggesting a potential role for PD-1-PD-L1 interaction in regulating T FH cell function. In fact, we show that engagement of PD-1 on T FH cells leads to a reduction in cell proliferation, activation, inducible T-cell co-stimulator (ICOS) expression and interleukin-21 (IL-21) cytokine secretion. Blocking PD-1 signaling enhances HIVspecific immunoglobulin production in vitro. We further show that at least part of this defect involves IL-21, as addition of this cytokine rescues antibody responses and plasma cell generation in vitro. Our results suggest that deregulation of T FH cell-mediated B cell help diminishes B cell responses during HIV infection and may be related to PD-1 triggering on T FH cells. These results demonstrate a role for T FH cell impairment in HIV pathogenesis and suggest that enhancing their function could have a major impact on the outcome and control of HIV infection, preventing future infections and improving immune responses to vaccinations.
During HIV infection there is a profound deregulation in B cell function [4] [5] [6] . However, little is known about the underlying mechanisms that alter B cell responses and antibody production at the site of their origin, the lymphoid tissues. The dynamic interplay between T FH cells and germinal center B cells is essential in establishing protective humoral immune responses. Furthermore, the rare and broadly neutralizing HIV-specific antibodies are enriched in somatic hypermutations [7] [8] [9] , a property that is largely the result of T FH cell interaction with germinal center B cells. It has further been shown, in the lymphocytic choriomeningitis virus mouse model, that sustained T FH cell function is required to control persistent viral infection 10, 11 . Preserving and enhancing T FH cell function could therefore prove imperative in promoting efficient humoral defenses against HIV and improving the outcome of vaccination in infected individuals.
We studied lymph node mononuclear cells (LNMCs) from healthy control subjects and antiretroviral therapy-naive, HIV-1-infected subjects (CD4 + T cell count >350 per mm 3 and plasma HIV RNA levels >2,000 copies per ml) (Supplementary Table 1 ). Initial characterization showed a significantly higher (P = 0.0012) frequency of T FH cells in HIV-infected lymph nodes (Fig. 1a) compared to healthy controls, and more than 90% of these cells expressed Bcl-6, the master regulator for T FH cells, and PD-1, confirming their T FH cell identity (Supplementary Fig. 1 ) 12 . We observed no significant differences in the naive, central memory or effector memory CD4 + T cell compartments ( Fig. 1a; Supplementary Fig. 2 shows gating strategies). We also observed a significantly higher (P < 0.0003) frequency of germinal center B cells and a significantly lower (P < 0.02) frequency of memory B cells in HIV-infected lymph nodes (Fig. 1b) . These results indicate that in HIV-infected lymph nodes there is an expansion of T FH cells and germinal center B cells that is probably driven by chronic infection and antigen accumulation within the follicular microenvironment 13, 14 . These results are in accordance with recently published reports in humans 15 and macaques 16, 17 .
To investigate whether the function of T FH cells is affected during HIV infection, we generated an in vitro coculture system in which sorted T FH or non-T FH cells are placed in culture with sorted autologous germinal center-enriched B cells in the presence of staphylococcal enterotoxin B (SEB). This coculture system allows for the quantification of T FH cell-mediated B cell help by measuring the accumulation of immunoglobulin in the culture supernatant and the absolute numbers of live cells at different time points (Supplementary Fig. 3 ). Using this assay we found that cocultures from HIV + lymph nodes had a 92% reduction in the concentration of IgG when compared to cocultures from control lymph nodes (Fig. 1c,d ). This reduction was also observed in cocultures from simian immunodeficiency virus (SIV) + macaques as compared to control animals ( Supplementary Fig. 4) . The absolute number of live B cells and T FH cells was also significantly (P < 0.01 and P < 0.02) lower in cocultures from human infected lymph nodes as compared to those from control lymph nodes after 7 d in coculture (Fig. 1e,f) . There was also less IL-10 in cocultures from HIV + subjects ( Supplementary  Fig. 5 ). We were unable, however, to quantify the amount of IL-21 in the supernatant, probably because of its rapid consumption by both T FH cells and B cells in the coculture. These results suggest that in lymph nodes from HIV + individuals, T FH cell function is altered, affecting B cell survival and antibody production.
We next explored the phenotype of T FH cells in HIV-infected and uninfected lymph nodes. T FH cells from HIV + and control lymph nodes expressed similar amounts of Bcl-6, ICOS, CD40 ligand and PD-1 (Fig. 2a,b and Supplementary Fig. 6 ). T FH cells sorted from infected and uninfected lymph nodes secreted similar amounts of cytokines, including IL-4, IL-10 and IL-21 after stimulation with phorbol myristate acetate (PMA) and ionomycin (Supplementary Fig. 7 ). In fact, we observed a tendency toward more IL-21 production by T FH cells from HIV-infected individuals. Thus, T FH cells from both infected and uninfected lymph nodes seem to be phenotypically similar, which suggests that the alteration in T FH cell function observed in the cocultures might arise from their interaction with B cells.
Given that HIV infection is known to affect intrinsic B cell function 4, 18, 19 , we investigated the status of lymph node-resident B cells. Naive, germinal center and memory B cells from lymph nodes of HIV + subjects expressed higher amounts of CD95 than their counterparts from control lymph nodes, suggesting they have an increased propensity to apoptosis (Supplementary Fig. 8 ). We next examined the capacity of B cells to survive without any T cell help and to produce immunoglobulin after polyclonal stimulation with CpG-B, a potent B cell stimulator that induces survival, differentiation and Ig secretion in human memory B cells 20 . We found that germinal center-enriched B cells from HIV + lymph nodes produced similar amounts of IgG to those from control lymph nodes (Supplementary Fig. 9a ). These cells were less viable, but not significantly, in HIV-infected lymph node (Supplementary Fig. 9b ). We also observed a tendency toward lower expression of IL-6 from germinal center-enriched B cells from HIV + lymph nodes ( Supplementary Fig. 9c ), which could have an impact on IL-21 secretion from T FH cells 21 .
As T FH cells express high amounts of the negative regulator PD-1, we next investigated whether expression of its ligands was high in B cell subsets from HIV + lymph nodes. A significantly (P = 0.015) higher frequency of germinal center B cells from HIV + lymph nodes expressed PD-L1 as compared to control lymph nodes (Fig. 2c) . This finding was specific for germinal center B cells, as naive, early memory and late memory B cells showed similar frequencies of PD-L1 expression compared to uninfected lymph nodes. We did not observe any differences in PD-L2 expression among B cell subsets (Fig. 2d) . Notably, staining of lymph node tissue sections from HIV + subjects showed abundant expression of PD-L1 within the follicles (Fig. 2e) . The levels of PD-L1 expression within the germinal center area were noticeably higher in lymph nodes from HIV + individuals compared to control lymph nodes, and this was also the case for lymph node samples from SIV-infected macaques (Fig. 2e) , in accordance with a recent study 16 . These results suggest that the higher frequency of PD-L1 + germinal center B cells in lymph nodes from HIV-infected subjects might affect T FH cell function.
We next examined whether PD-1 ligation on T FH cells could result in functional alterations that would affect B cell help. We sorted T FH cells from uninfected tonsils and cultured them in the presence of npg beads coated with anti-CD3, anti-CD28 and chimeric recombinant human PD-L1 (PD-L1 beads) to ligate PD-1 in the context of T cell receptor activation or in the presence of beads coated with anti-CD3, anti-CD28 and isotype control (control beads), or we left them unstimulated. When we cultured T FH cells in the presence of control beads there was a significant (P < 0.001) induction of Ki-67 and CD38 expression, suggesting an increased proliferative capacity. However, stimulation with PD-L1 beads lowered the frequencies of Ki-67 + and CD38 + T FH cells (Fig. 3a) . Moreover, PD-1 ligation decreased the frequency and absolute number of live T FH cells (Fig. 3b) . The reduction in Ki-67 expression was maintained after 5 d (Fig. 3c) . Unexpectedly, ligating PD-1 also inhibited ICOS expression (Fig. 3d) , which could affect IL-4 and IL-21 cytokine secretion 22 . In fact, PD-1 ligation led to a 60% decrease in the concentration of IL-21 ( Fig. 3e) and 78% and 95% decreases in the concentrations of IL-4 and IL-10, respectively (Supplementary Fig. 10 ). These results suggest that PD-1 ligation on T FH cells affects their proliferation, survival and cytokine secretion.
Cocultures from HIV + lymph nodes showed reduced B cell survival and Ig secretion. If PD-1 ligation on T FH cells from HIV + lymph nodes affects IL-21 secretion, which is crucial for B cell survival and differentiation into plasma cells, then supplementation with IL-21 might restore and enhance antibody production. In fact, cocultures of T FH cells from infected lymph nodes showed a significant restoration in IgG production when supplemented with IL-21 to the IgG levels observed in cocultures from control lymph nodes (Fig. 4a,b) . Addition of IL-21 increased the amount of IgG produced by B cells in the coculture and led to a dose-dependent increase in CD27 mean fluorescence intensity on B cells, suggesting the accumulation of plasma cells as these express the highest level of CD27 (Fig. 4c) . IL-21 supplementation also led to a dose-dependent increase in the absolute number of live B cells (Fig. 4d) , in accordance with the ability of IL-21 to promote B cell differentiation, survival and proliferation in the context of B cell help 23 .
We next determined whether exogenous IL-21 could affect HIVspecific T FH cell-mediated B cell responses. We sorted T FH cells and germinal center-enriched B cells and cultured them with primed monocytes for 7 d in the presence or absence of IL-21. Addition of IL-21 enhanced antigen-specific, T FH cell-mediated IgG production (Fig. 4e) . We also tested whether blocking PD-1 engagement with its ligands could restore antibody production. For this, we cultured T FH cells, B cells and primed monocytes in the presence or absence of blocking antibodies to PD-L1 and PD-L2 or isotype control. Blocking PD-L1 and PD-L2 increased IgG production by 78% when compared to the isotype control group (Fig. 4f) . There was no change in the levels of IgG when the PD-1 pathway was blocked in cocultures from uninfected subjects (Supplementary Fig. 11 ). Overall, these results highlight a potential role for PD-1 engagement and IL-21 in altering T FH cell-mediated B cell help during HIV infection. They further indicate that interfering with PD-1 triggering could enhance HIV-specific humoral defenses that are compromised during HIV infection.
Even though T FH cells from control and HIV + lymph nodes were phenotypically similar, the function of these cells from HIV + lymph Fig. 4b ), we observed that only germinal center-enriched B cells from SIV + macaques, which also express a higher frequency of PD-L1 (Fig. 2e) , affected T FH cell-mediated IgG production when compared to cocultures with GC B cells before infection. These results reinforce idea that T FH cells from infected subjects are not dysfunctional, but rather their function is affected once they come into contact with PD-L1-expressing B cells.
Here we propose a model in which HIV infection drives the expansion of both T FH and germinal center B cells, but the heightened levels of activation and antigen overload increase the frequency of PD-L1 + germinal center B cells. This leads to excessive and persistent triggering of PD-1 on T FH cells, which affects their capacity to provide adequate B cell help. This effect, combined with the B cell-intrinsic defects shown here, results in the inability to mount appropriate T FH cell-mediated B cell responses. Even though HIV-infected subjects show hypergammaglobulinemia, this probably arises from npg hyperactivated naive B cells in the periphery 1 . Similarly, an increase in SIV-specific antibodies has been associated with the accumulation of T FH cells 17 , but their level and function could be suboptimal, preventing the generation of efficient antibody responses (magnitude and breadth). Alternatively, these SIV-specific antibodies could have been generated independently of T FH cells. Of note, in this study we were unable to distinguish T FH cells from T follicular regulatory cells, which also express CXCR5 and could affect T FH cell-mediated B cell responses [24] [25] [26] [27] . It will be important to determine the presence and function of these cells during HIV infection. PD-L1 expression on B cells has been shown to negatively regulate T FH cell expansion in mice 28 . Here we show that PD-1 triggering affects T FH cell function leading to reduced ICOS expression, which might affect downstream transcription factors such as c-Maf 29-3 1 and subsequently IL-4 and IL-21 cytokine secretion, thereby affecting B cell help (Supplementary Fig. 12 ). It is known that the majority of HIV-infected individuals do not develop broadly neutralizing antibodies and the small percentage that do have a delay of years in their generation 4, 32, 33 . To what extent the alteration in T FH cell function has an impact on the timing of production and on the quality of neutralizing antibodies remains to be determined.
The signals leading to increased PD-L1 expression on germinal center B cells are unclear, but they are likely the result of increased levels of interferons that can upregulate PD-L1 expression 34 . Treatment of mice with blocking antibodies to PD-L1 or PD-1 has been shown to enhance T FH cell expansion and function and increase the number of germinal center B cells, plasmablasts and antigen-specific antibody responses 28, 35 . Similarly, PD-1 blockade in macaques improved humoral responses and increased SIV-specific antibody responses 36 .
Despite the fact that PD-1 and PD-L1 ligation impairs T FH cellmediated B cell help, our results and data from others 15, 17 showed elevated frequencies of both T FH and GC B cells in infected lymph nodes. This increase in T FH and GC B cell frequencies is probably the result of constant antigenic stimulation resulting in T FH cell differentiation and GC B cell induction leading to the development of large numbers of germinal centers. This is in accordance with the increased frequency of GCs observed in the lymph nodes from SIV + macaques 16 . We show that the efficiency of germinal center responses could be compromised during HIV and SIV infection, probably as a result of increased and persistent ligation of PD-1 on T FH cells by PD-L1 on GC B cells. Not all T FH cell-GC B cell interactions would involve PD-1 ligation on T FH cells, still allowing for some HIV-specific antibody production. However, T FH cells in HIV-infected subjects could lose their ability to properly generate robust HIV-specific and de novo humoral responses to new infections or vaccinations. Consistent with this suggestion are the reduced antibody responses to hepatitis B, measles, mumps and rubella vaccines in HIV + subjects 2, 37, 38 . Reduced antibody responses have also been shown in macaques, in which SIV infection led to reduced frequency of antibody-secreting memory B cells specific to Leishmania major polyprotein when compared to uninfected animals 39 . Our work shows that T FH cell-mediated B cell responses are impaired during HIV infection. We suggest that for effective vaccination of HIV-infected individuals and to improve HIV-specific responses, the integrity of function of T FH cells needs to be considered.
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Methods and any associated references are available in the online version of the paper.
